Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men

Autor: Maggi, M, Debruyne, F. M. J., Behre, H. M. b, Roehrborn, C. G. c, F. C. W. e, Wu, Schröder, F. H. f, Jones, T. H. g, Porst, H. h, Hackett, G. i, Wheaton, O. A. j, Martin-Morales, A. k, Meuleman, E. l, Cunningham, G. R. m, Divan, H. A. j, Rosen, jEmail Author, R. C., the RHYME Investigators, Dohle G., N, Arver S., N, Lenzi A., N, Stroberg P., N, Maggio M., N, Cruz N., N, Balercia G., N, Yassin A., N, Reisman C., N, Bassa L., N, Pescatori E., N, Martinez, Salamanca, J. I., N, Romero, Otero, n Jockenhoevel, J.

Publikováno v: BJU International, 119(2), 216-224. Wiley-Blackwell Publishing Ltd
BJU International. Wiley-Blackwell
Debruyne, F M J, Behre, H M, Roehrborn, C G, Maggi, M, Wu, F C W, Schröder, F H, Jones, T H, Porst, H, Hackett, G, Wheaton, O A, Martin-Morales, A, Meuleman, E, Cunningham, G R, Divan, H A, Rosen, R C & RHYME Investigators 2016, ' Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms : prostate health outcomes in the Registry of Hypogonadism in Men ', BJU International . https://doi.org/10.1111/bju.13578

OBJECTIVES: To evaluate the effects of testosterone-replacement therapy (TRT) on prostate health indicators in hypogonadal men, including rates of prostate cancer diagnoses, changes in prostate-specific antigen (PSA) levels and lower urinary tract sy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c681fe34d0e4048623f383720632110c
http://hdl.handle.net/2158/1071384